Castlight Health (CSLT) Tops Q2 EPS by 2c

Castlight Health (NYSE: CSLT) reported Q2 EPS of ($0.11), $0.02 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $23.6 million versus the consensus estimate of $23.09 million.

"In the second quarter Castlight added nearly $7 million of signed annual recurring revenue and continued to gain traction among large enterprises, including notable customers such as Caterpillar and Genentech," said Giovanni Colella, M.D., co-founder and chief executive officer of Castlight Health. "We had strong adoption of Castlight's health benefits platform across our new customers and saw increased contribution from our channel relationships, in particular Anthem, which provide validation of both our expanding value proposition and the evolution of our go-to-market strategy."

GUIDANCE:

Castlight Health sees FY2016 EPS of ($0.40)-($0.42), versus the consensus of ($0.41). Castlight Health sees FY2016 revenue of $99-102 million, versus the consensus of $100.6 million.

For earnings history and earnings-related data on Castlight Health (CSLT) click here.

You May Also Be Interested In

• Equifax (EFX) shares tumble on weak Q1 revenue, guidance miss
• Nokia slightly down as Q1 profit growth fails to meet consensus; outlook unchanged
• Texas Capital Bancshares (TCBI) Misses Q1 EPS by 12c